| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 685964 | Null | 0.0129421834592789 | 0.29551907 |
| NSC 686554 | 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- | 0.0129421834592789 | 0.26989192 |
| NSC 688228 | Null | 0.0129421834592789 | 0.27247362 |
| NSC 694509 | Null | 0.0129421834592789 | 0.27740965 |
| NSC 718630 | Null | 0.0129421834592789 | 0.52972703 |
| NSC 726217 | Combretastatin A4-analogue | 0.0129421834592789 | 0.33173388 |
| NSC 726442 | 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride | 0.0129421834592789 | 0.35912564 |
| NSC 728078 | 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide | 0.0129421834592789 | 0.36211582 |
| NSC 732962 | 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone | 0.0129421834592789 | 0.43328483 |
| NSC 734949 | 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide | 0.012942183459279 | 0.19225446 |